欢迎来到天天文库
浏览记录
ID:55315096
大小:166.99 KB
页数:2页
时间:2020-05-14
《肝病治疗仪治疗慢性乙型肝炎的临床观察.pdf》由会员上传分享,免费在线阅读,更多相关内容在行业资料-天天文库。
1、临床医药文献杂志2015年2月A第2卷第4期626JournalofClinicalMedicalLiteratureFeb.A2015V_01.2No.4肝病治疗仪治疗慢性乙型肝炎的临床观察胡日旺(山西省大同市第四人民医院,山西大同037008)【摘要】目的探讨在慢性乙型肝炎患者中,应用肝病治疗仪治疗方案的疗效。方法选取我院于2O13年7月~2014年6月收治的慢性乙型肝炎患者80例进行分析,将其随机分为对照组(40例)和观察组(40/f4)。对照组采用常规药物治疗方案,观察组采用肝病治疗仪治疗方案。观察两组患者的疗效。
2、结果两组患者在乏力、腹胀、纳差、黄疸、肝区不适等·『盘床症状的治疗有效率上相比差异无统计学意义(P>0.05)。但观察组患者治疗后的肝功能指标明显优于对照组,不良反应的发生率(5.0%)明显低于对照组(17.5%),差异具有统计学意义(P3、095—8242.2015.04.626.02ClinicalobservationOfliverdiseasetherapyinstrumentinthetreatmentofchronichepatitisBHURi-wan~(TheFourthPeople’SHospitalofShanxi,Province,DatongShanxiDatong037008,China)【Abstract】ObjectiveTostudytheinpatientswithchronichepatitisb.1iverdiseaset4、reatmentinstrumentapplicationtheclinicalemcacyoftreatment.MethodsToselectourhospitalfromJuly2013tOJune2014,80casesofpatientswithchronichepatitisbwereanalyzed,anditswererandomlydividedintocontrolgroup(40cases)andobservationgroup(40cases).Controlgroupusingconvention5、aldrugtreatment,observationgroupwithliverdiseasetherapeutictreatment.Toobserveclinicaltherapeuticeffectoftwogroupsofpatients.ResultsTwogroupsofpatientsinweakness,abdominaldistention,poorappetite,jaundice,liverareaunwellonthetreatmentofclinicalsymptoms,suchaseficie6、ntcomparedwiththediference,isnotstatisticallysignificantfP>0.05).Buttheobservationgroupofpatientsaftertreatmentofliverfunctionindexissuperiortocontrolgroup,theincidenceofadversereactions(5.0%),significantlylowerthanthecontrolgroup(17.5%),statisticallysignificantdi7、fferences(P<0.05),withstatisticalsignificance.ConclusionForpatientswithchronichepatitisb,theconventionaldrugtherapyand1iverdiseasetherapeutictreatment.clinicaleficacy.butusetheliverfunctionrecoveryofpatientswithliverdiseasetherapeuticapparatusmoreapparent,lowerinc8、idenceofadversereactions,recommendedtouse.[Keywords]Chronichepatitisb:Liverdiseasetherapeuticapparatus;Drugtherapy;Clinicalcurativeefect乙型病毒肝炎在世界范围内的感染率
3、095—8242.2015.04.626.02ClinicalobservationOfliverdiseasetherapyinstrumentinthetreatmentofchronichepatitisBHURi-wan~(TheFourthPeople’SHospitalofShanxi,Province,DatongShanxiDatong037008,China)【Abstract】ObjectiveTostudytheinpatientswithchronichepatitisb.1iverdiseaset
4、reatmentinstrumentapplicationtheclinicalemcacyoftreatment.MethodsToselectourhospitalfromJuly2013tOJune2014,80casesofpatientswithchronichepatitisbwereanalyzed,anditswererandomlydividedintocontrolgroup(40cases)andobservationgroup(40cases).Controlgroupusingconvention
5、aldrugtreatment,observationgroupwithliverdiseasetherapeutictreatment.Toobserveclinicaltherapeuticeffectoftwogroupsofpatients.ResultsTwogroupsofpatientsinweakness,abdominaldistention,poorappetite,jaundice,liverareaunwellonthetreatmentofclinicalsymptoms,suchaseficie
6、ntcomparedwiththediference,isnotstatisticallysignificantfP>0.05).Buttheobservationgroupofpatientsaftertreatmentofliverfunctionindexissuperiortocontrolgroup,theincidenceofadversereactions(5.0%),significantlylowerthanthecontrolgroup(17.5%),statisticallysignificantdi
7、fferences(P<0.05),withstatisticalsignificance.ConclusionForpatientswithchronichepatitisb,theconventionaldrugtherapyand1iverdiseasetherapeutictreatment.clinicaleficacy.butusetheliverfunctionrecoveryofpatientswithliverdiseasetherapeuticapparatusmoreapparent,lowerinc
8、idenceofadversereactions,recommendedtouse.[Keywords]Chronichepatitisb:Liverdiseasetherapeuticapparatus;Drugtherapy;Clinicalcurativeefect乙型病毒肝炎在世界范围内的感染率
此文档下载收益归作者所有